Can Tikosyn and Digoxin Be Co-Administered?
Yes, Tikosyn (dofetilide) and digoxin can be given together, but this combination requires heightened vigilance due to an increased risk of Torsade de Pointes, despite no pharmacokinetic interaction between the drugs. 1
Key Evidence from FDA Labeling
The FDA label for Tikosyn explicitly addresses this combination 1:
- Pharmacokinetic studies in healthy volunteers showed that Tikosyn does not affect digoxin levels - there is no drug-drug interaction affecting absorption, distribution, or elimination
- However, in clinical patient populations, concomitant digoxin administration was associated with a higher occurrence of Torsade de Pointes
- Importantly, no increase in mortality was observed in patients taking both medications
The Clinical Nuance
The increased Torsade de Pointes risk appears related to patient factors rather than a true drug interaction:
- Patients requiring digoxin typically have more severe structural heart disease
- Structural heart disease is itself an independent risk factor for ventricular arrhythmias
- The FDA label acknowledges: "It is not clear whether this represents an interaction with TIKOSYN or the presence of more severe structural heart disease in patients on digoxin" 1
Practical Management Algorithm
When combining these medications:
- Ensure proper Tikosyn initiation protocol - hospitalization with continuous ECG monitoring for 3 days 1
- Monitor QTc interval closely - check baseline and serially during initiation
- Maintain electrolyte balance - keep potassium and magnesium in normal range (hypokalemia/hypomagnesemia dramatically increase Torsade risk)
- Dose Tikosyn based on creatinine clearance - both drugs are renally eliminated 1
- Monitor digoxin levels - aim for lower therapeutic range (0.5-0.9 ng/mL) given contemporary evidence suggesting increased mortality above 1.2 ng/mL 2
Supporting Research Evidence
A dedicated pharmacokinetic study confirmed that 5 days of dofetilide treatment did not significantly affect steady-state digoxin levels, and no digoxin dose adjustment is needed 3. An expert review from 2000 explicitly states that "dofetilide can be co-administered with digoxin and beta-blockers" 4.
Critical Pitfalls to Avoid
- Do not assume the combination is contraindicated - it is not, unlike verapamil, ketoconazole, trimethoprim, or HCTZ which are absolute contraindications with Tikosyn 1
- Do not neglect the mandatory hospitalization requirement for Tikosyn initiation regardless of concomitant medications
- Do not allow electrolyte abnormalities - this is the most modifiable risk factor for Torsade de Pointes
- Recognize that digoxin is listed among rate control options in contemporary AF guidelines alongside Tikosyn as a rhythm control agent 2, 5
The combination is permissible and commonly used in clinical practice, particularly in patients with atrial fibrillation requiring both rate and rhythm control strategies.